Cytogenetic abnormalities in a series of 1029 patients with primary myelodysplastic syndromesOlga Pozdnyakova, Sa A. Wang, Ottó Walter et al.|Cancer|2008Cited by 113
Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibilityJeffrey W. Craig, Olga Pozdnyakova, Michael J. Mina et al.|PLoS ONE|2018Cited by 9
Assessment of CD52 Expression in Double-Hit and Double-Expressor Lymphomas: Implications for Clinical Trial EligibilityJeffrey W. Craig, Olga Pozdnyakova, Geraldine S. Pinkus et al.|Blood|2017Cited by 0